Skip to content

Characterising Arm Recovery in People With Severe Stroke

Characterising Arm Recovery in People With Severe Stroke

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02464085
Acronym
CARPSS
Enrollment
50
Registered
2015-06-08
Start date
2015-07-31
Completion date
2019-12-31
Last updated
2017-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Stroke, Upper limb, Neuroplastic change, Longitudinal, Function

Brief summary

The main goal of this program of research is to advance our understanding of how the severely damaged brain changes over the first 12-months post stroke. The investigators will determine 'who recovers', 'who does not recover', and 'why'

Detailed description

The main goal of this program of research is to advance our understanding of how the severely damaged brain changes over the first 12-months post stroke. The prevalence and severity of stroke related arm disability is increasing and the prospect of optimal recovery is poor. Studies have demonstrated that stroke survivors with severe disability lack early indicators (\<7-days to \<1-month post-stroke) of a good prognosis, such as active movement at the shoulder and wrist and integrity of the corticospinal tract. This has propagated the clinical belief that this cohort are unlikely to functionally benefit from rehabilitation efforts. However, it is possible that indicators of potential for recovery - either neuroanatomical or clinical - may present in individuals with severe stroke later, that is beyond the early time-period. Indeed, there is increasing evidence of the potential for ongoing improvements in motor performance in response to intensive interventions that are undertaken 6-months or more post-stroke. This therefore, implies that there is some degree of untapped recovery potential. However, as very few studies have longitudinally explored the potential indicators of recovery in a severe cohort, the dynamic capacity of the severely damaged remains unknown. Thus, there is a need to determine 'who recovers', 'who does not recover', and 'why' to be able to promote optimal arm recovery in people with severe impairment after stroke. We will assess stroke survivors \<4-weeks, 3-months, 6-months and 12-months post stroke using a range of neuroimaging and clinical outcome measures. The findings from this study will build the foundations for more personalized health care options for people with severe arm impairment post stroke.

Interventions

OTHERLongitudinal evaluation of recovery

Stroke survivors will be assessed at four time frames post stroke to evaluate neuroplastic and clinical changes in arm recovery over the first 12-months post stroke.

Sponsors

University of British Columbia
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* adults aged 18 to 90 years; * sustained their first stroke; * demonstrate subacute (\<1 month) and severe upper limb motor deficits (defined by a SAFE \[shoulder abduction and finger extension\] score of \<5 out of 10 points); and * can follow single stage commands

Exclusion criteria

* neurological condition other than stroke e.g., Parkinson's disease

Design outcomes

Primary

MeasureTime frameDescription
3T Magnetic Resonance Imaging (MRI)up to 12-monthsDetermine the structural and functional connectivity of the brain using diffusion weighted imaging, resting state-functional magnetic resonance imaging and myelin water fraction imaging.

Secondary

MeasureTime frameDescription
Motor Assessment Scale items 6,7,8<4wks, 3-months, 6-months, 12-monthsMeasurement of upper limb activity
REACH (Rating of Everyday Arm Use in the Community and Home)<4wks, 3-months, 6-months, 12-monthsSelf-report measure of everyday arm use
Accelerometry<4wks, 3-months, 6-months, 12-monthsMeasurement of real world arm use (activity count) over a 7-day period at each time frame
Shoulder abduction and finger extension (SAFE)12-monthsMeasurement of upper limb strength
PASS (Postural Assessment Scale for Stroke patients)<4wks, 3-months, 6-months, 12-monthsMeasurement of balance (static and dynamic) and lower limb functional tasks
10-metre walk test<4wks, 3-months, 6-months, 12-monthsMeasurement of walking ability
Fugl-Meyer Assessment (arm and sensory)<4wks, 3-months, 6-months, 12-monthsMeasurement of upper limb impairment
Dose of upper limb training<4wks, 3-months, 6-months, 12-monthsDose in minutes of passive, active, functional or sensory upper limb tasks performed over a 7-day period at each time frame
National Institute of Stroke Severity Scale<4-weeksCharacterise stroke severity
Oxfordshire Bamford Classification<4-weeksCharacterise stroke type
Myelin water fraction imaging (WMI)<4wks, 3-months, 6-months, 12-monthsDetermine the myelin content within the brain
Meaningful arm recovery questionnaire<4wks, 3-months, 6-months, 12-monthsExplore the stroke survivor's perception of meaningful recovery of their upper limb
Montreal Cognitive Assessment (MoCA)<4wks, 3-months, 6-months, 12-monthsMeasurement of cognitive impairment after stroke

Countries

Canada

Contacts

Primary ContactKathryn S Hayward, PT PhD
kathryn.hayward@ubc.ca6048273369
Backup ContactLara A Boyd, PT PhD
lara.boyd@ubc.ca6048273369

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026